PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia

Leukemia. 2017 Mar;31(3):738-743. doi: 10.1038/leu.2016.328. Epub 2016 Nov 14.

Authors

D Goltz¹, H Gevensleben¹, S Grünen¹, J Dietrich², G Kristiansen¹, J Landsberg³, D Dietrich^{1

2}

Affiliations

¹ Institute of Pathology, University Hospital Bonn, Bonn, Germany.
² Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany.
³ Department of Dermatology, University Hospital Bonn, Bonn, Germany.

PMID: 27840427
DOI: 10.1038/leu.2016.328

No abstract available

MeSH terms

B7-H1 Antigen / genetics*
Epigenesis, Genetic / genetics
Female
Humans
Immunity, Innate / genetics
Inflammation / genetics
Leukemia, Myeloid, Acute / genetics*
Male
Methylation
Middle Aged
Promoter Regions, Genetic / genetics*
T-Lymphocytes / pathology
Up-Regulation / genetics

Substances

B7-H1 Antigen
CD274 protein, human